Black Rock Inc. Nektar Therapeutics Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Nektar Therapeutics stock. As of the latest transaction made, Black Rock Inc. holds 5,878,293 shares of NKTR stock, worth $7.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,878,293

Previous 6,104,217 3.7%

Holding current value

$7.29 Million

Previous $3.42 Million 59.92%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.49 - $0.96 $110,702 - $216,887	-225,924 Reduced 3.7%	5,878,293 $5.47 Million
Q4 2023 Feb 13, 2024	SELL	$0.42 - $0.57 $663,773 - $900,834	-1,580,412 Reduced 20.57%	6,104,217 $3.42 Million
Q3 2023 Nov 13, 2023	SELL	$0.51 - $1.05 $469,043 - $965,677	-919,693 Reduced 10.69%	7,684,629 $4.61 Million
Q2 2023 Aug 11, 2023	SELL	$0.53 - $1.03 $14.3 Million - $27.8 Million	-26,954,636 Reduced 75.8%	8,604,322 $4.99 Million
Q1 2023 May 12, 2023	SELL	$0.64 - $3.15 $237,924 - $1.17 Million	-371,757 Reduced 1.03%	35,558,958 $24.9 Million

Q4 2022 Feb 13, 2023	BUY	$2.03 - $4.28 $1.79 Million - $3.77 Million	880,196 Added 2.51%	35,930,715 $81.2 Million
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $10.6 Million - $17.9 Million	3,477,606 Added 11.01%	35,050,519 $112 Million
Q2 2022 Aug 12, 2022	BUY	$3.17 - $6.17 $17.3 Million - $33.7 Million	5,458,398 Added 20.9%	31,572,913 $120 Million
Q1 2022 May 12, 2022	SELL	$4.16 - $13.72 $2.32 Million - $7.65 Million	-557,288 Reduced 2.09%	26,114,515 $141 Million
Q4 2021 Feb 10, 2022	BUY	$10.83 - $18.41 $84.8 Million - $144 Million	7,827,559 Added 41.54%	26,671,803 $360 Million
Q3 2021 Nov 09, 2021	BUY	$13.07 - $18.84 $3.24 Million - $4.67 Million	247,972 Added 1.33%	18,844,244 $338 Million
Q2 2021 Aug 11, 2021	BUY	$16.52 - $20.4 $307 Million - $379 Million	18,596,272 New	18,596,272 $319 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $232M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account